Denmark clinical cannabis sales publish a favorable quarter many thanks to Epidiolex


A longer variation of this tale shows up at Marijuana Company Daily International.

Sales of clinical marijuana in Denmark uploaded healthy and balanced gains in the 3rd quarter of 2020, accompanying the launch of GW Pharmaceuticals’ CBD medication Epidiolex.

Total sales of all median cannabis items expanded from regarding 13 million Danish Krones ($ 2 million) in the 2nd quarter to virtually 16 million Danish Krones in the 3rd quarter, standing for a gain of greater than 20%.

Yet income within the nation’s pilot program, which enables sales of blossom and also oil without advertising consent, stays little and also much from the top seen one year earlier.

In the 3rd quarter of 2020, just 12.5% of complete income produced by clinical cannabis sales originated from items marketed as component of the pilot program, main information programs.

That is below very early 2019, when deals in the pilot program stood for 40% of the complete clinical cannabis sales.

The greatest adjustment from the previous quarter was a significant rise of sales in the classification of completed pharmaceutical items with advertising consent, described by the begin of GW Pharmaceuticals’ Epidiolex sales.

The classification of magistral prep work– medications prepared in a drug store from separated THC and/or CBD– reduced accompanying the begin of Epidiolex sales, an indicator that some CBD prescriptions changed from magistral prep work to Epidiolex, a completed pharmaceutical item.

Audit for all clinical cannabis items, complete sales throughout the 3rd quarter had to do with 15.7 million Danish krone, of which:

  • The pilot program stood for just 12.5% of the total amount.
  • Magistral prep work with pure THC or pure CBD– no full-spectrum items– represented virtually half of all sales.
  • A 3rd of the sales represented complete pharmaceutical items with advertising consent. Nearly all the income in this classification was produced by Epidiolex sales, which began in mid-2020; the remainder are attributable to GW Pharmaceuticals’ various other signed up medication, Sativex.
  • The staying 6% represented various other completed pharmaceutical items that do not have advertising consent in Denmark, generally UNITED STATE Food and also Medicine Administration-approved Marinol.
READ  Cannabichromene-- Just How CBC Interacts With Our Mind's "Happiness" Particle to Target Clinical Depression
READ  The Daily Struck: April 20, 2021 

Thinking about all kinds of items, 6,130 people got a prescription for clinical cannabis a minimum of as soon as from January 2018 till September 2020– most for separated cannabinoids magistral prep work.

Alfredo Pascual can be gotten to at [email protected]

Denmark medical cannabis, Denmark medical cannabis sales post a positive quarter thanks to Epidiolex


The declarations made worrying these items have not been assessed by the Foods and also Medicine Management. The effectiveness of those goods has actually not been verified by FDA-approved evaluation. These goods are typically not suggested to detect, take care of, treatment, or prevent any type of health problem. All information located right below will certainly not be suggested as an alternate selection to or various from information from health treatment specialists. Please look for the suggestions of your health treatment knowledgeable regarding prospective communications or various achievable problems previously than making use of any type of item. The Federal Foods, Medicine and also Elegance Act needs this exploration.

Stay in Touch

To follow the best marijuana and CBD news.

Related Articles